These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8029806)

  • 1. Influence of endothelium-derived relaxing factor on platelet function and hemostasis in vivo.
    Houston DS; Buchanan MR
    Thromb Res; 1994 Apr; 74(1):25-37. PubMed ID: 8029806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelium-derived relaxing factor modulates platelet aggregation in an in vivo model of recurrent platelet activation.
    Golino P; Cappelli-Bigazzi M; Ambrosio G; Ragni M; Russolillo E; Condorelli M; Chiariello M
    Circ Res; 1992 Dec; 71(6):1447-56. PubMed ID: 1423938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NG-nitro-L-arginine antagonizes endothelium-dependent dilator responses by inhibiting endothelium-derived relaxing factor release in the isolated rabbit heart.
    Lamontagne D; Pohl U; Busse R
    Pflugers Arch; 1991 Apr; 418(3):266-70. PubMed ID: 1649992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous endothelium-derived relaxing factor inhibits platelet adhesion under whole blood flow conditions ex vivo.
    Jen CJ; Chen CT; Chen H
    Chin J Physiol; 1995; 38(3):147-51. PubMed ID: 8846723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelium-derived relaxing factor inhibits platelet adhesion to cultured porcine endocardial endothelium.
    Siney L; Lewis MJ
    Eur J Pharmacol; 1992 Dec; 229(2-3):223-6. PubMed ID: 1283374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the release of endothelium-derived relaxing factor in vitro and in vivo by dipeptides containing NG-nitro-L-arginine.
    Thiemermann C; Mustafa M; Mester PA; Mitchell JA; Hecker M; Vane JR
    Br J Pharmacol; 1991 Sep; 104(1):31-8. PubMed ID: 1786515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired tissue perfusion after inhibition of endothelium-derived nitric oxide.
    Pohl U; Lamontagne D
    Basic Res Cardiol; 1991; 86 Suppl 2():97-105. PubMed ID: 1953621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of prostacyclin, EDRF and active oxygens in leukocyte-dependent platelet adhesion to endothelial cells induced by platelet-activating factor in vitro.
    Hirafuji M; Shinoda H
    Br J Pharmacol; 1993 Jun; 109(2):524-9. PubMed ID: 8358552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of NG-nitro-L-arginine methyl ester upon basal blood flow and endothelium-dependent vasodilatation in the dog hindlimb.
    White DG; Drew GM; Gurden JM; Penny DM; Roach AG; Watts IS
    Br J Pharmacol; 1993 Mar; 108(3):763-8. PubMed ID: 8467362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological reactivity of human epicardial coronary arteries: characterization of relaxation responses to endothelium-derived relaxing factor.
    Stork AP; Cocks TM
    Br J Pharmacol; 1994 Dec; 113(4):1099-104. PubMed ID: 7889260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of vasodilatation to levcromakalim by hypoxia and EDRF in the rabbit isolated ear: a comparison with pinacidil, sodium nitroprusside and verapamil.
    Randall MD; Griffith TM
    Br J Pharmacol; 1993 Jun; 109(2):386-93. PubMed ID: 8358541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the inhibitory potencies of N(G)-methyl-, N(G)-nitro- and N(G)-amino-L-arginine on EDRF function in the rat: evidence for continuous basal EDRF release.
    Vargas HM; Cuevas JM; Ignarro LJ; Chaudhuri G
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1208-15. PubMed ID: 1646327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets.
    Radomski MW; Palmer RM; Moncada S
    Br J Pharmacol; 1987 Sep; 92(1):181-7. PubMed ID: 3311265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of bradykinin in the rat isolated perfused heart: role of kinin receptors and endothelium-derived relaxing factor.
    Baydoun AR; Woodward B
    Br J Pharmacol; 1991 Jul; 103(3):1829-33. PubMed ID: 1657268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of the vasorelaxant activity of nitric oxide by hydroxyguanidine: implications for the nature of endothelium-derived relaxing factor.
    Zembowicz A; Swierkosz TA; Southan GJ; Hecker M; Vane JR
    Br J Pharmacol; 1992 Dec; 107(4):1001-7. PubMed ID: 1281716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of oxygen and exogenous L-arginine on EDRF activity in fetal pulmonary circulation.
    McQueston JA; Cornfield DN; McMurtry IF; Abman SH
    Am J Physiol; 1993 Mar; 264(3 Pt 2):H865-71. PubMed ID: 8456989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thimerosal blocks stimulated but not basal release of endothelium-derived relaxing factor (EDRF) in dog isolated coronary artery.
    Crack P; Cocks T
    Br J Pharmacol; 1992 Oct; 107(2):566-72. PubMed ID: 1384915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different patterns of release of endothelium-derived relaxing factor and prostacyclin.
    Mitchell JA; de Nucci G; Warner TD; Vane JR
    Br J Pharmacol; 1992 Feb; 105(2):485-9. PubMed ID: 1373103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.
    Palmer RM; Ferrige AG; Moncada S
    Nature; 1987 Jun 11-17; 327(6122):524-6. PubMed ID: 3495737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide (EDRF) enhances the vasorelaxing effect of nitrendipine in various isolated arteries.
    Günther J; Dhein S; Rösen R; Klaus W; Fricke U
    Basic Res Cardiol; 1992; 87(5):452-60. PubMed ID: 1463429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.